UNITED THERAPEUTICS CORP (UTHR) Stock Analyst Ratings
NASDAQ:UTHR - Nasdaq - US91307C1027 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to UTHR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 412.24. This target is 14.16% above the current price.
UTHR was analyzed by 21 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about UTHR.
In the previous month the buy percentage consensus was at a similar level.
UTHR was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-08 | UBS | Maintains | Buy -> Buy |
| 2024-11-01 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-10-31 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2024-10-31 | Argus Research | Maintains | Buy -> Buy |
| 2024-10-31 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-21 | TD Cowen | Maintains | Buy -> Buy |
| 2024-09-23 | Jefferies | Maintains | Buy -> Buy |
| 2024-08-28 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-08-01 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-11 | TD Cowen | Maintains | Buy -> Buy |
| 2024-07-11 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-07-08 | UBS | Maintains | Buy -> Buy |
| 2024-06-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-05-21 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-03 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-05-02 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-02-22 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-02-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-12 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2024-02-05 | Leerink Partners | Initiate | Outperform |
| 2023-11-02 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-11-02 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-11-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-03 | Ladenburg Thalmann | Maintains | Buy -> Buy |